We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TELO market cap is 14.23M. The company's latest EPS is CAD -0.0396 and P/E is -5.05.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.05M | -1.31M | -1.26M | -2.11M | -2.82M |
| Net Income | -1.07M | -1.24M | -1.07M | -2.11M | -2.82M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 262k | 1.17M | 3.84M | 2.83M | 2.93M |
| Total Liabilities | 1.31M | 393k | 154k | 230k | 313k |
| Total Equity | -1.05M | 775k | 3.69M | 2.6M | 2.61M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -328k | -1.12M | -1.11M | -1.8M | -2.63M |
| Investing | N/A | -8k | -9k | -25k | -69k |
| Financing | 280k | 2.03M | 3.83M | 876k | 2.68M |
| Market Cap | 14.23M |
| Price to Earnings Ratio | -5.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.32 |
| Price to Book Ratio | 5.45 |
| Dividend Yield | - |
| Shares Outstanding | 71.16M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (6.98%) |
| Company Name | Telo Genomics Corporation |
| Address |
1200-750 west pender st vancouver, british columbia V6C 2T8 |
| Website | https://www.telodx.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
